INTRA-CELLULAR THERAPIES, INC. The registrant is filing this Exhibit 99.1 for the purpose of incorporating the information set forth herein by reference into the registration statement on Form S-3 (File No. 333-235817) that was filed by the registrant with the Securities and Exchange Commission on January 6, 2020 and became effective upon filing.
The following table sets forth the estimated costs and expenses, other than underwriting discounts and commissions, payable by the registrant in connection with the sale of the securities being registered:
SEC Registration Fee | $ | 42,642 | ||
Printing and Mailing Expenses | $ | 20,000 | ||
Legal Fees and Expenses | $ | 160,000 | ||
Accounting Fees and Expenses | $ | 150,000 | ||
Transfer Agent and Registrar Fees | $ | 5,000 | ||
Miscellaneous | $ | 22,358 | ||
Total | $ | 400,000 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Intra-Cellular Therapies Inc. published this content on 05 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 January 2022 22:17:09 UTC.
